154 related articles for article (PubMed ID: 20592555)
1. Evaluation of the clinical performance of high-risk human papillomavirus testing for primary screening: a retrospective review of the Southern California Permanente Medical Group experience.
Lonky NM; Mahdavi A; Wolde-Tsadik G; Bajamundi K; Felix JC
J Low Genit Tract Dis; 2010 Jul; 14(3):200-5. PubMed ID: 20592555
[TBL] [Abstract][Full Text] [Related]
2. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
3. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
Fletcher AH; Wilkinson EJ; Knapik JA
J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
6. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
8. HPV testing and vaccination in Europe.
Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology.
Rebolj M; Lynge E; Ejegod D; Preisler S; Rygaard C; Bonde J
Gynecol Oncol; 2014 Dec; 135(3):474-80. PubMed ID: 25449563
[TBL] [Abstract][Full Text] [Related]
10. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
Nishino HT; Tambouret RH; Wilbur DC
Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
[TBL] [Abstract][Full Text] [Related]
11. Introduction of human papillomavirus DNA screening in the world: 15 years of experience.
Castle PE; de Sanjosé S; Qiao YL; Belinson JL; Lazcano-Ponce E; Kinney W
Vaccine; 2012 Nov; 30 Suppl 5():F117-22. PubMed ID: 23199954
[TBL] [Abstract][Full Text] [Related]
12. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Oštrbenk A; Xu L; Arbyn M; Poljak M
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30209184
[TBL] [Abstract][Full Text] [Related]
14. New technologies and procedures for cervical cancer screening.
Cuzick J; Bergeron C; von Knebel Doeberitz M; Gravitt P; Jeronimo J; Lorincz AT; J L M Meijer C; Sankaranarayanan R; J F Snijders P; Szarewski A
Vaccine; 2012 Nov; 30 Suppl 5():F107-16. PubMed ID: 23199953
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
16. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening.
Luo H; Belinson JL; Du H; Liu Z; Zhang L; Wang C; Qu X; Pretorius RG; Wu R
J Low Genit Tract Dis; 2017 Jan; 21(1):12-16. PubMed ID: 27851695
[TBL] [Abstract][Full Text] [Related]
18. The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.
Schmeink CE; Bekkers RL; Massuger LF; Melchers WJ
Rev Med Virol; 2011 May; 21(3):139-53. PubMed ID: 21538664
[TBL] [Abstract][Full Text] [Related]
19. [Research of the relationship between cervical cytology and HPV test and lesions in the cervical tissue].
Zhang LD; Xie W; Pei J; Zhao D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):276-8. PubMed ID: 23189843
[TBL] [Abstract][Full Text] [Related]
20. Age-specific performance of careHPV versus Papanicolaou and visual inspection of cervix with acetic acid testing in a primary cervical cancer screening.
Labani S; Asthana S
J Epidemiol Community Health; 2016 Jan; 70(1):72-7. PubMed ID: 26248549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
